On Monday, June 15, 2020, the U.S. Food and Drug Administration removed the Emergency Authorization Use (EAU) of two malaria drugs to treat COVID-19, saying that they are “unlikely to be effective.”

Both hydroxychloroquine (brand name Plaquenil) and chloroquine were heavily promoted by President Trump after a handful of small, poorly controlled studies showed that they could work in treating the disease.

The FDA reported that further studies had shown that the two drugs were unlikely to be effective in stopping the virus, and that current national treatment guidelines do not recommend using them outside of clinical trials.

Hydroxychloroquine is a low-risk ototoxic drug. Please refer to this feature article for more information.

Share this

Recent Posts

President’s Message: Academy Teamwork

“Huh?” Is More Than an Interrogatory Palindrome!

Volunteer Spotlight: Riley DeBacker, AuD, PhD

Related Posts

“Huh?” Is More Than an Interrogatory Palindrome!

“Huh?” is used in at least 31 languages around the world! A version of the word can be found in nearly every language on Earth (Dingemanse et al, 2013). This research concluded that all languages studied included a word similar, in both sound and function, to the English “huh?” Regardless of language, the word is…

Read More

Another Useless Body Part…

If you have a dog or cat, you’ve probably seen their ears moving toward an interesting or startling sound. For professional equestrians, watching the ears of their horse allows them to gauge their shifting attention. Humans still have these same muscles, and even more interesting is their relationship to our brain and how we pay attention. …

Read More

Memorizing Movements: How Tai Chi Can Improve Balance and Cognition

Tai Chi is not just for increasing balance; it may also help improve cognitive performance. In a recent randomized controlled trial, study participants who practiced a form of Tai Chi twice a week for six months improved their scores on the Montreal Cognitive Assessment (MoCA) when compared to a control group (Fuzhong et al, 2023)….

Read More